Vivos Inc. reported that it just certified the New England Equine Practice in Patterson, NY to administer Precision Radionuclide IsoPet® therapy for treating solid tumors in horses. IsoPet® is a next generation treatment option, providing a same day therapy, using relatively low activity to deliver a high therapeutic dose that stays at the injection site with no contamination in the urine or feces. This is an important feature as horses should not be trailered more than eight hours or they can develop serious medical respiratory issues called trailer fever the following day.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1878 USD | -6.05% | +15.36% | +159.75% |
05-09 | Vivos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-18 | Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+159.75% | 77.94M | |
-3.61% | 15.11B | |
-12.11% | 2.48B | |
-14.52% | 1.43B | |
-.--% | 1.12B | |
+56.51% | 614M | |
+86.41% | 509M | |
+19.71% | 260M | |
-2.35% | 227M | |
+7.96% | 198M |
- Stock Market
- Equities
- RDGL Stock
- News Vivos Inc.
- Vivos Inc. Announces a New IsoPet® Precision Radionuclide Therapy Regional Clinic for Equine Therapy